BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Paradise WA, Vesper BJ, Goel A, Waltonen JD, Altman KW, Haines GK, Radosevich JA. Nitric oxide: perspectives and emerging studies of a well known cytotoxin. Int J Mol Sci 2010;11:2715-45. [PMID: 20717533 DOI: 10.3390/ijms11072715] [Cited by in Crossref: 34] [Cited by in F6Publishing: 27] [Article Influence: 3.1] [Reference Citation Analysis]
Number Citing Articles
1 Kumar N, Bhalla V, Kumar M. Recent developments of fluorescent probes for the detection of gasotransmitters (NO, CO and H2S). Coordination Chemistry Reviews 2013;257:2335-47. [DOI: 10.1016/j.ccr.2013.02.028] [Cited by in Crossref: 137] [Cited by in F6Publishing: 110] [Article Influence: 17.1] [Reference Citation Analysis]
2 Aqil M, Deliu Z, Elseth KM, Shen G, Xue J, Radosevich JA. Part II-mechanism of adaptation: A549 cells adapt to high concentration of nitric oxide through bypass of cell cycle checkpoints. Tumour Biol 2014;35:2417-25. [PMID: 24241959 DOI: 10.1007/s13277-013-1319-5] [Cited by in Crossref: 4] [Cited by in F6Publishing: 6] [Article Influence: 0.5] [Reference Citation Analysis]
3 Scicinski J, Oronsky B, Ning S, Fanger GR, Knox SJ, Bednarski M. Discovery and Development of RRx-001, a Novel Nitric Oxide and ROS Mediated Epigenetic Modulator. In: Bonavida B, editor. Nitric Oxide and Cancer: Pathogenesis and Therapy. Cham: Springer International Publishing; 2015. pp. 259-77. [DOI: 10.1007/978-3-319-13611-0_16] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.2] [Reference Citation Analysis]
4 Sugimoto M, Sakagami H, Yokote Y, Onuma H, Kaneko M, Mori M, Sakaguchi Y, Soga T, Tomita M. Non-targeted metabolite profiling in activated macrophage secretion. Metabolomics 2012;8:624-33. [DOI: 10.1007/s11306-011-0353-9] [Cited by in Crossref: 63] [Cited by in F6Publishing: 22] [Article Influence: 6.3] [Reference Citation Analysis]
5 Korde (Choudhari) S, Sridharan G, Gadbail A, Poornima V. Nitric oxide and oral cancer: A review. Oral Oncology 2012;48:475-83. [DOI: 10.1016/j.oraloncology.2012.01.003] [Cited by in Crossref: 31] [Cited by in F6Publishing: 26] [Article Influence: 3.4] [Reference Citation Analysis]
6 Mohammadi F, Kohlmeier KA, Jeddi S, Ahmadi-Zeidabadi M, Shabani M. Affective dimensions of pain and region -specific involvement of nitric oxide in the development of empathic hyperalgesia. Sci Rep 2020;10:10141. [PMID: 32576847 DOI: 10.1038/s41598-020-66930-w] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
7 Reid T, Oronsky B, Scicinski J, Scribner CL, Knox SJ, Ning S, Peehl DM, Korn R, Stirn M, Carter CA, Oronsky A, Taylor MJ, Fitch WL, Cabrales P, Kim MM, Burris HA Rd, Lao CD, Abrouk NED, Fanger GR, Infante JR. Safety and activity of RRx-001 in patients with advanced cancer: a first-in-human, open-label, dose-escalation phase 1 study. Lancet Oncol 2015;16:1133-42. [PMID: 26296952 DOI: 10.1016/S1470-2045(15)00089-3] [Cited by in Crossref: 50] [Cited by in F6Publishing: 32] [Article Influence: 8.3] [Reference Citation Analysis]
8 Hu X, Wang J, Zhu X, Dong D, Zhang X, Wu S, Duan C. A copper(ii) rhodamine complex with a tripodal ligand as a highly selective fluorescence imaging agent for nitric oxide. Chem Commun 2011;47:11507. [DOI: 10.1039/c1cc14032a] [Cited by in Crossref: 62] [Cited by in F6Publishing: 59] [Article Influence: 6.2] [Reference Citation Analysis]
9 Burke AJ, Sullivan FJ, Giles FJ, Glynn SA. The yin and yang of nitric oxide in cancer progression. Carcinogenesis 2013;34:503-12. [PMID: 23354310 DOI: 10.1093/carcin/bgt034] [Cited by in Crossref: 222] [Cited by in F6Publishing: 200] [Article Influence: 27.8] [Reference Citation Analysis]
10 Hu X, Zhang X, Song H, He C, Bao Y, Tang Q, Duan C. A novel copper(Ⅱ) complex-based fluorescence probe for nitric oxide detecting and imaging. Tetrahedron 2012;68:8371-5. [DOI: 10.1016/j.tet.2012.04.002] [Cited by in Crossref: 13] [Cited by in F6Publishing: 13] [Article Influence: 1.4] [Reference Citation Analysis]
11 Seabra AB, Rai M, Durán N. Nano carriers for nitric oxide delivery and its potential applications in plant physiological process: A mini review. J Plant Biochem Biotechnol 2014;23:1-10. [DOI: 10.1007/s13562-013-0204-z] [Cited by in Crossref: 40] [Cited by in F6Publishing: 16] [Article Influence: 5.0] [Reference Citation Analysis]
12 Staurengo-Ferrari L, Zarpelon AC, Longhi-Balbinot DT, Marchesi M, Cunha TM, Alves-Filho JC, Cunha FQ, Ferreira SH, Casagrande R, Miranda KM, Verri WA Jr. Nitroxyl inhibits overt pain-like behavior in mice: role of cGMP/PKG/ATP-sensitive potassium channel signaling pathway. Pharmacol Rep 2014;66:691-8. [PMID: 24948073 DOI: 10.1016/j.pharep.2014.04.003] [Cited by in Crossref: 14] [Cited by in F6Publishing: 13] [Article Influence: 2.0] [Reference Citation Analysis]
13 Vesper BJ, Onul A, Haines GK 3rd, Tarjan G, Xue J, Elseth KM, Aydogan B, Altman MB, Roeske JC, Paradise WA, De Vitto H, Radosevich JA. Part I. Molecular and cellular characterization of high nitric oxide-adapted human breast adenocarcinoma cell lines. Tumour Biol 2013;34:203-14. [PMID: 23238815 DOI: 10.1007/s13277-012-0530-0] [Cited by in Crossref: 8] [Cited by in F6Publishing: 9] [Article Influence: 0.9] [Reference Citation Analysis]
14 Virtuoso LP, Harden JL, Sotomayor P, Sigurdson WJ, Yoshimura F, Egilmez NK, Minev B, Kilinc MO. Characterization of iNOS(+) Neutrophil-like ring cell in tumor-bearing mice. J Transl Med 2012;10:152. [PMID: 22846631 DOI: 10.1186/1479-5876-10-152] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.2] [Reference Citation Analysis]
15 De Vitto H, Mendonça BS, Elseth KM, Onul A, Xue J, Vesper BJ, Gallo CV, Rumjanek FD, Paradise WA, Radosevich JA. Part III. Molecular changes induced by high nitric oxide adaptation in human breast cancer cell line BT-20 (BT-20-HNO): a switch from aerobic to anaerobic metabolism. Tumour Biol 2013;34:403-13. [PMID: 23238817 DOI: 10.1007/s13277-012-0564-3] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.1] [Reference Citation Analysis]
16 Lindermayr C, Rudolf EE, Durner J, Groth M. Interactions between metabolism and chromatin in plant models. Mol Metab 2020;38:100951. [PMID: 32199818 DOI: 10.1016/j.molmet.2020.01.015] [Cited by in Crossref: 15] [Cited by in F6Publishing: 13] [Article Influence: 15.0] [Reference Citation Analysis]
17 Aqil M, Elseth KM, Vesper BJ, Deliu Z, Aydogan B, Xue J, Radosevich JA. Part I-mechanism of adaptation: high nitric oxide adapted A549 cells show enhanced DNA damage response and activation of antiapoptotic pathways. Tumour Biol 2014;35:2403-15. [PMID: 24241898 DOI: 10.1007/s13277-013-1318-6] [Cited by in Crossref: 8] [Cited by in F6Publishing: 11] [Article Influence: 1.0] [Reference Citation Analysis]
18 Yang X, Ebrahimi A, Li J, Cui Q. Fullerene-biomolecule conjugates and their biomedicinal applications. Int J Nanomedicine 2014;9:77-92. [PMID: 24379667 DOI: 10.2147/IJN.S52829] [Cited by in Crossref: 19] [Cited by in F6Publishing: 16] [Article Influence: 2.4] [Reference Citation Analysis]
19 Puyaubert J, Baudouin E. New clues for a cold case: nitric oxide response to low temperature. Plant Cell Environ 2014;37:2623-30. [DOI: 10.1111/pce.12329] [Cited by in Crossref: 61] [Cited by in F6Publishing: 48] [Article Influence: 8.7] [Reference Citation Analysis]
20 Habib S, Ali A. Biochemistry of nitric oxide. Indian J Clin Biochem 2011;26:3-17. [PMID: 22211007 DOI: 10.1007/s12291-011-0108-4] [Cited by in Crossref: 57] [Cited by in F6Publishing: 47] [Article Influence: 5.7] [Reference Citation Analysis]
21 Deliu Z, Tamas T, Chowdhury J, Aqil M, Bassiony M, Radosevich JA. Expression of cross-tolerance to a wide range of conditions in a human lung cancer cell line after adaptation to nitric oxide. Tumour Biol 2017;39:1010428317723778. [PMID: 28936924 DOI: 10.1177/1010428317723778] [Cited by in F6Publishing: 1] [Reference Citation Analysis]
22 Jain P, Satapathy T, Pandey RK. Efficacy of arecoline hydrobromide against cattle tick Rhipicephalus (Boophilus) microplus. International Journal of Acarology 2020;46:268-75. [DOI: 10.1080/01647954.2020.1765018] [Cited by in Crossref: 7] [Cited by in F6Publishing: 4] [Article Influence: 7.0] [Reference Citation Analysis]
23 Aqil M, Elseth KM, Arjunakani A, Nebres P, Amegashie CP, Thanki DH, Desai PB, Radosevich JA. A549 cells adapted to high nitric oxide show reduced surface CEACAM expression and altered adhesion and migration properties. Tumour Biol 2015;36:1871-9. [PMID: 25500969 DOI: 10.1007/s13277-014-2789-9] [Cited by in Crossref: 3] [Cited by in F6Publishing: 2] [Article Influence: 0.4] [Reference Citation Analysis]
24 Cury Y, Picolo G, Gutierrez VP, Ferreira SH. Pain and analgesia: The dual effect of nitric oxide in the nociceptive system. Nitric Oxide 2011;25:243-54. [DOI: 10.1016/j.niox.2011.06.004] [Cited by in Crossref: 167] [Cited by in F6Publishing: 152] [Article Influence: 16.7] [Reference Citation Analysis]
25 Demircan B, Yucel B, Radosevich JA. DNA Methylation in Human Breast Cancer Cell Lines Adapted to High Nitric Oxide. In Vivo 2020;34:169-76. [PMID: 31882476 DOI: 10.21873/invivo.11758] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
26 Carpenter AW, Schoenfisch MH. Nitric oxide release: part II. Therapeutic applications. Chem Soc Rev 2012;41:3742-52. [PMID: 22362384 DOI: 10.1039/c2cs15273h] [Cited by in Crossref: 527] [Cited by in F6Publishing: 462] [Article Influence: 58.6] [Reference Citation Analysis]
27 Egilmez NK, Harden JL, Virtuoso LP, Schwendener RA, Kilinc MO. Nitric oxide short-circuits interleukin-12-mediated tumor regression. Cancer Immunol Immunother 2011;60:839-45. [PMID: 21387108 DOI: 10.1007/s00262-011-0998-2] [Cited by in Crossref: 12] [Cited by in F6Publishing: 12] [Article Influence: 1.2] [Reference Citation Analysis]